President Donald Trump plans to fire FDA Commissioner Marty Makary, signaling renewed turmoil at a key U.S. health regulator. The move is negative for policy stability and may increase uncertainty around FDA oversight and decision-making, but it is unlikely by itself to drive broad market moves.
President Donald Trump plans to fire FDA Commissioner Marty Makary, signaling renewed turmoil at a key U.S. health regulator. The move is negative for policy stability and may increase uncertainty around FDA oversight and decision-making, but it is unlikely by itself to drive broad market moves.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
mildly negative
Sentiment Score
-0.20
